Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines
A revolutionary advancement in X-ray photoelectron spectroscopy depth profiling
Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets
Next-generation HEK293 transient expression system is driving breakthroughs in therapeutic development
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC
Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field
New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions
As part of the agreement, Thermo Fisher will manage the sales, distribution, and customer support for Massbox in Europe and China
Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency
New research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers
The Vanquish CAD P Series helps laboratories achieve reliable results faster to drive performance, confidence and convenience in daily analytical testing
New analytical instruments and innovative software to drive breakthroughs in biopharmaceutical discovery, translational omics and safer water quality
Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry
Researchers can obtain deeper insights from cells with more colors and faster time to results with minimal sample volume
Designed to enable scientists to conduct small-scale experiments quickly and affordably
Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization
First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact
The new Krios 5 Cryo-TEM enables breakthroughs in structural and cellular biology to pioneer new treatments and advance drug discovery
The new genetic analyzer supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing
New alliance for advanced biological imaging aimed at enhancing some of the world's most innovative structural cell biology capabilities to help scientists answer pressing research questions
